Analyst Price Target is $11.72
▲ +205.66% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Curaleaf in the last 3 months. The average price target is $11.72, with a high forecast of $15.00 and a low forecast of $8.50. The average price target represents a 205.66% upside from the last price of $3.84.
Current Consensus is
The current consensus among 9 polled investment analysts is to buy stock in Curaleaf. This Buy consensus rating has held steady for over two years.
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Cannabis Operations and Non-Cannabis Operations segments. The Cannabis Operations segment includes the production and sale of cannabis via retail and wholesale channels. The Non-Cannabis Operations segment provides professional services including cultivation, processing and retail know-how and back office administration, intellectual property licensing, real estate leasing services and lending facilities to medical and adult-use cannabis licensees under management service agreements. The company was founded on November 13, 2014 and is headquartered in Wakefield, MA.